Chiglitazar/Metformin in Non-obese Women With PCOS

Clinical trial NCT06125587 · COMPLETED

Trial details

NCT number: NCT06125587
Sponsor: Shengjing Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome Chiglitazar Metformin

Start date: 2023-11-15
Primary completion: 2024-10-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.